Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Breast Neoplasms 3Stomach Neoplasms 1Psychological Well-Being 1Psoriasis 1Peripheral Nervous System Diseases 1Osteoarthritis 1Neoplasms 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Cardiovascular Diseases 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Dexamethasone 238Lenalidomide 145daratumumab 123Bortezomib 101pomalidomide 86Calcium Dobesilate 76carfilzomib 74Cyclophosphamide 70Specimen Handling 42isatuximab 40Biopsy 40fludarabine 36belantamab mafodotin 36Magnetic Resonance Spectroscopy 35talquetamab 29dexamethasone acetate 27dexamethasone 21-phosphate 27Melphalan 27auricularum 26iberdomide 25ixazomib 22fludarabine phosphate 22selinexor 21elotuzumab 21Whole-Body Irradiation 14X-Rays 13tocilizumab 12venetoclax 11Mycophenolic Acid 10trametinib 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Multiple Myeloma × Fish Oils × 1 year × Clear all
NCT07403071 2026-02-11

Validating Fish Oil's Role in Alleviating Bortezomib-Induced Neuropathy: A Multi-Method Study Integrating Big Data, Experimental, and Clinical Research

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Not yet recruiting
200 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡